Pael receptor is involved in dopamine metabolism in the nigrostriatal system

Neurosci Res. 2007 Dec;59(4):413-25. doi: 10.1016/j.neures.2007.08.005. Epub 2007 Aug 15.

Abstract

Pael receptor (Pael-R) has been identified as one of the substrates of Parkin, a ubiquitin ligase responsible for autosomal recessive juvenile Parkinsonism (AR-JP). When Parkin is inactivated, unfolded Pael-R accumulates in the endoplasmic reticulum and results in neuronal death by unfolded protein stress, suggesting that Pael-R has an important role in the pathogenesis of AR-JP. Here we report the analyses on Pael-R-deficient (KO) and Pael-R-transgenic (Tg) mice. The striatal dopamine (DA) level of Pael-R KO mice was only 60% of that in normal mice, while in Pael-R Tg mice, striatal 3,4-dihydroxyphenylacetic acid (DOPAC) as well as vesicular DA content increased. Moreover, the nigrostriatal dopaminergic neurons of Pael-R Tg mice are more vulnerable to Parkinson's disease-related neurotoxins while those of Pael-R KO mice are less. These results strongly suggest that the Pael-R signal regulates the amount of DA in the dopaminergic neurons and that excessive Pael-R expression renders dopaminergic neurons susceptible to chronic DA toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / adverse effects
  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Corpus Striatum / metabolism*
  • Corpus Striatum / physiopathology
  • Dopamine / metabolism*
  • Drug Resistance / genetics
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Male
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Neural Pathways / metabolism*
  • Neural Pathways / physiopathology
  • Neurotoxins / toxicity
  • Oxidopamine / toxicity
  • Parkinsonian Disorders / genetics
  • Parkinsonian Disorders / metabolism
  • Parkinsonian Disorders / physiopathology
  • Receptors, G-Protein-Coupled / genetics*
  • Substantia Nigra / metabolism*
  • Substantia Nigra / physiopathology
  • Ubiquitin-Protein Ligases / metabolism

Substances

  • GPR37 receptor, human
  • Neurotoxins
  • Receptors, G-Protein-Coupled
  • 3,4-Dihydroxyphenylacetic Acid
  • Oxidopamine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Dopamine